Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies

References

• Almeida PEd, Pereira de Sousa NM, Rampinelli PG, Silva RVdS, Correa JR, D’Avila H. 2023. Lipid droplets as multifunctional organelles related to the mechanism of evasion during mycobacterial infection. Front Cell Infect Microbiol. 13:1102643. doi: 10.3389/fcimb.2023.1102643.
   PubMed Web of Science ®Google Scholar
• Andries K, Verhasselt P, Guillemont J, Göhlmann HWH, Neefs J-M, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, et al. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science (1979). 307(5707):223–227. doi: 10.1126/science.1106753.
   PubMed Web of Science ®Google Scholar
• Augenstreich J, Haanappel E, Sayes F, Simeone R, Guillet V, Mazeres S, Chalut C, Mourey L, Brosch R, Guilhot C, et al. 2020. phthiocerol dimycocerosates from Mycobacterium tuberculosis increase the membrane activity of bacterial effectors and host receptors. Front Cell Infect Microbiol. 10:420. doi: 10.3389/fcimb.2020.00420.
   Google Scholar
• Banks DA, Ahlbrand SE, Hughitt VK, Shah S, Mayer-Barber KD, Vogel SN, El-Sayed NM, Briken V. 2019. Mycobacterium tuberculosis inhibits autocrine type I IFN signaling to increase intracellular survival. J Immunol. 202(8):2348–2359. doi: 10.4049/jimmunol.1801303.
   PubMed Web of Science ®Google Scholar
• Barkan D, Hedhli D, Yan HG, Huygen K, Glickman MS. 2012. Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice. Infect Immun. 80(6):1958–1968. doi: 10.1128/IAI.00021-12.
   PubMed Web of Science ®Google Scholar
• Barrientos OM, Langley E, González Y, Cabello C, Torres M, Guzmán-Beltrán S. 2022. Mycobacterium tuberculosis whiB3 and lipid metabolism genes are regulated by host induced oxidative stress. Microorganisms. 10(9):1821. doi: 10.3390/microorganisms10091821.
   PubMed Web of Science ®Google Scholar
• Basu P, Sandhu N, Bhatt A, Singh A, Balhana R, Gobe I, Crowhurst NA, Mendum TA, Gao L, Ward JL, et al. 2018. The anaplerotic node is essential for the intracellular survival of Mycobacterium tuberculosis. J Biol Chem. 293(15):5695–5704. doi: 10.1074/jbc.RA118.001839.
   PubMed Web of Science ®Google Scholar
• Bazet Lyonnet B, Diacovich L, Cabruja M, Bardou F, Quémard A, Gago G, Gramajo H. 2014. Pleiotropic effect of AccD5 and AccE5 depletion in acyl-coenzyme a carboxylase activity and in lipid biosynthesis in mycobacteria. PLoS One. 9(6):e99853. doi: 10.1371/journal.pone.0099853.
   PubMed Web of Science ®Google Scholar
• Bedard M, van der Niet S, Bernard EM, Babunovic G, Cheng T-Y, Aylan B, Grootemaat AE, Raman S, Botella L, Ishikawa E, et al. 2023. A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages. J Clin Investigat. 133(6):1–17. doi: 10.1172/JCI161944.
   Web of Science ®Google Scholar
• Beites T, Jansen RS, Wang R, Jinich A, Rhee KY, Schnappinger D, Ehrt S. 2021. Multiple acyl-CoA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection. Nat Commun. 12(1):6593. doi: 10.1038/s41467-021-26941-1.
   PubMed Web of Science ®Google Scholar
• Birch HL, Alderwick LJ, Bhatt A, Rittmann D, Krumbach K, Singh A, Bai Y, Lowary TL, Eggeling L, Besra GS, et al. 2008. Biosynthesis of mycobacterial arabinogalactan: identification of a novel α(1→3) arabinofuranosyltransferase. Mol Microbiol. 69(5):1191–1206. doi: 10.1111/j.1365-2958.2008.06354.x.
   PubMed Web of Science ®Google Scholar
• Boland R, Heemskerk MT, Forn-Cuní G, Korbee CJ, Walburg KV, Esselink JJ, Carvalho dos Santos C, de Waal AM, van der Hoeven DCM, van der Sar E, et al. 2023. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis. mBio. 14(1):e0302422. doi: 10.1128/mbio.03024-22.
   PubMed Web of Science ®Google Scholar
• Boldrin F, Anso I, Alebouyeh S, Sevilla IA, Geijo M, Garrido JM, Marina A, Cioetto Mazzabò L, Segafreddo G, Guerin ME, et al. 2021. The phosphatidyl-myo-inositol dimannoside acyltransferase PatA is essential for mycobacterium tuberculosis growth in vitro and in vivo. J Bacteriol. 203(7):e00439-20. doi: 10.1128/JB.00439-20.
   PubMed Web of Science ®Google Scholar
• Boldrin F, Ventura M, Degiacomi G, Ravishankar S, Sala C, Svetlikova Z, Ambady A, Dhar N, Kordulakova J, Zhang M, et al. 2014. The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo. J Bacteriol. 196(19):3441–3451. doi: 10.1128/JB.01346-13.
   PubMed Web of Science ®Google Scholar
• Bozza PT, Bakker-Abreu I, Navarro-Xavier RA, Bandeira-Melo C. 2011. Lipid body function in eicosanoid synthesis: an update. Prostaglandins Leukot Essent Fatty Acids. 85(5):205–213. doi: 10.1016/j.plefa.2011.04.020.
   PubMed Web of Science ®Google Scholar
• Braverman J, Sogi KM, Benjamin D, Nomura DK, Stanley SA. 2016. HIF-1α is an essential mediator of IFN-γ–dependent immunity to Mycobacterium tuberculosis. The Journal of Immunology. 197(4):1287–1297. doi: 10.4049/jimmunol.1600266.
   PubMed Web of Science ®Google Scholar
• Brown KL, Wilburn KM, Montague CR, Grigg JC, Sanz O, Pérez-Herrán E, Barros D, Ballell L, VanderVen BC, Eltis LD, et al. 2023. Cyclic AMP-mediated inhibition of cholesterol catabolism in Mycobacterium tuberculosis by the novel drug candidate GSK2556286. Antimicrob Agents Chemother. 67(1):e0129422. doi: 10.1128/aac.01294-22.
   PubMed Web of Science ®Google Scholar
• Brzostek A, Pawelczyk J, Rumijowska-Galewicz A, Dziadek B, Dziadek J. 2009. Mycobacterium tuberculosis is able to accumulate and utilize cholesterol. J Bacteriol. 191(21):6584–6591. doi: 10.1128/JB.00488-09.
   PubMed Web of Science ®Google Scholar
• Caire-Brändli I, Papadopoulos A, Malaga W, Marais D, Canaan S, Thilo L, de Chastellier C. 2014. Reversible lipid accumulation and associated division arrest of mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis. Infect Immun. 82(2):476–490. doi: 10.1128/IAI.01196-13.
   PubMed Web of Science ®Google Scholar
• Carey AF, Rock JM, Krieger IV, Chase MR, Fernandez-Suarez M, Gagneux S, Sacchettini JC, Ioerger TR, Fortune SM. 2018. TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities. PLoS Pathog. 14(3):e1006939. doi: 10.1371/journal.ppat.1006939.
   PubMed Web of Science ®Google Scholar
• Coelho C. 2022. Itaconate or how i learned to stop avoiding the study of immunometabolism. PLoS Pathog. 18(3):e1010361. doi: 10.1371/journal.ppat.1010361.
   PubMed Web of Science ®Google Scholar
• Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, III, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 393(6685):537–544. & doi: 10.1038/31159.
   PubMed Web of Science ®Google Scholar
• D’Avila H, Melo RCN, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT. 2006. Mycobacterium bovis bacillus calmette-guérin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J Immunol. 176(5):3087–3097. doi: 10.4049/jimmunol.176.5.3087.
   PubMed Web of Science ®Google Scholar
• Daleke MH, Cascioferro A, de Punder K, Ummels R, Abdallah AM, van der Wel N, Peters PJ, Luirink J, Manganelli R, Bitter W, et al. 2011. Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway. Journal of Biological Chemistry. 286(21):19024–19034. doi: 10.1074/jbc.M110.204966.
   PubMed Web of Science ®Google Scholar
• Daniel J, Deb C, Dubey VS, Sirakova TD, Abomoelak B, Morbidoni HR, Kolattukudy PE. 2004. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J Bacteriol. 186(15):5017–5030. doi: 10.1128/JB.186.15.5017-5030.2004.
   PubMed Web of Science ®Google Scholar
• Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. 2011. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7(6):e1002093. doi: 10.1371/journal.ppat.1002093.
   PubMed Web of Science ®Google Scholar
• Daniel J, Oh TJ, Lee CM, Kolattukudy PE. 2007. AccD6, a member of the Fas II locus, is a functional carboxyltransferase subunit of the acyl-coenzyme A carboxylase in Mycobacterium tuberculosis. J Bacteriol. 189(3):911–917. doi: 10.1128/JB.01019-06.
   PubMed Web of Science ®Google Scholar
• Daniel J, Sirakova T, Kolattukudy P. 2014. An Acyl-CoA synthetase in mycobacterium tuberculosis involved in triacylglycerol accumulation during dormancy. PLoS One. 9(12):e114877. doi: 10.1371/journal.pone.0114877.
   PubMed Web of Science ®Google Scholar
• Deb C, Daniel J, Sirakova TD, Abomoelak B, Dubey VS, Kolattukudy PE. 2006. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in mycobacterium tuberculosis. J Biol Chem. 281(7):3866–3875. doi: 10.1074/jbc.M505556200.
   PubMed Web of Science ®Google Scholar
• DeJesus MA, Gerrick ER, Xu W, Park SW, Long JE, Boutte CC, Rubin EJ, Schnappinger D, Ehrt S, Fortune SM, et al. 2017. Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis. mBio. 8(1):e02133–16. doi: 10.1128/mBio.02133-16.
   PubMed Web of Science ®Google Scholar
• Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, et al. 2017. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 5(4):291–360. doi: 10.1016/S2213-2600(17)30079-6.
   Web of Science ®Google Scholar
• Dinadayala P, Kaur D, Berg S, Amin AG, Vissa VD, Chatterjee D, Brennan PJ, Crick DC. 2006. Genetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis. J Biol Chem. 281(29):20027–20035. doi: 10.1074/jbc.M603395200.
   PubMed Web of Science ®Google Scholar
• Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. 2010. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol. 11(8):751–758. doi: 10.1038/ni.1904.
   PubMed Web of Science ®Google Scholar
• Drage MG, Tsai H-C, Pecora ND, Cheng T-Y, Arida AR, Shukla S, Rojas RE, Seshadri C, Moody DB, Boom WH, et al. 2010. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nat Struct Mol Biol. 17(9):1088–1095. doi: 10.1038/nsmb.1869.
   PubMed Web of Science ®Google Scholar
• Eoh H, Rhee KY. 2014. Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of mycobacterium tuberculosis on fatty acids. Proc Natl Acad Sci USA. 111(13):4976–4981. doi: 10.1073/pnas.1400390111.
   PubMed Web of Science ®Google Scholar
• Fay A, Czudnochowski N, Rock JM, Johnson JR, Krogan NJ, Rosenberg O, Glickman MS. 2019. Two accessory proteins govern MmpL3 mycolic acid transport in mycobacteria. mBio. 10(3):e00850–19. doi: 10.1128/mBio.00850-19.
   PubMed Web of Science ®Google Scholar
• Fineran P, Lloyd-Evans E, Lack NA, Platt N, Davis LC, Morgan AJ, Höglinger D, Tatituri RVV, Clark S, Williams IM, et al. 2016. Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway. Wellcome Open Res. 1:18. doi: 10.12688/wellcomeopenres.10036.1.
   PubMedGoogle Scholar
• Fratti RA, Chua J, Vergne I, Deretic V. 2003. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci USA. 100(9):5437–5442. doi: 10.1073/pnas.0737613100.
   PubMed Web of Science ®Google Scholar
• Ganapathy U, Marrero J, Calhoun S, Eoh H, de Carvalho LPS, Rhee K, Ehrt S. 2015. Two enzymes with redundant fructose bisphosphatase activity sustain gluconeogenesis and virulence in Mycobacterium tuberculosis. Nat Commun. 6:7912. doi: 10.1038/ncomms8912.
   Web of Science ®Google Scholar
• Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, et al. 2010. LRRK2 is involved in the IFN-γ response and host response to pathogens. J Immunol. 185(9):5577–5585. doi: 10.4049/jimmunol.1000548.
   PubMed Web of Science ®Google Scholar
• Gaur RL, Ren K, Blumenthal A, Bhamidi S, Gibbs S, Jackson M, Zare RN, Ehrt S, Ernst JD, Banaei N, et al. 2014. LprG-mediated surface expression of lipoarabinomannan is essential for virulence of mycobacterium tuberculosis. PLoS Pathog. 10(9):e1004376. doi: 10.1371/journal.ppat.1004376.
   PubMed Web of Science ®Google Scholar
• Gavalda S, Léger M, van der Rest B, Stella A, Bardou F, Montrozier H, Chalut C, Burlet-Schiltz O, Marrakchi H, Daffé M, et al. 2009. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. J Biol Chem. 284(29):19255–19264. doi: 10.1074/jbc.M109.006940.
   PubMed Web of Science ®Google Scholar
• Gibson AJ, Stiens J, Passmore IJ, Faulkner V, Miculob J, Willcocks S, Coad M, Berg S, Werling D, Wren BW, et al. 2022. Defining the Genes required for survival of Mycobacterium bovis in the bovine host offers novel insights into the genetic basis of survival of pathogenic mycobacteria. mBio. 13(4):e0067222. doi: 10.1128/mbio.00672-22.
   PubMed Web of Science ®Google Scholar
• Gioffré A, Infante E, Aguilar D, Santangelo MDlP, Klepp L, Amadio A, Meikle V, Etchechoury I, Romano MI, Cataldi A, et al. 2005. Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect. 7(3):325–334. doi: 10.1016/j.micinf.2004.11.007.
   PubMed Web of Science ®Google Scholar
• Goossens SN, Sampson SL, Rie AV. 2020. Mechanisms of drug-induced tolerance in mycobacterium tuberculosis. Clin Microbiol Rev. 34(1):e00141-20. doi: 10.1128/CMR.00141-20.
   PubMed Web of Science ®Google Scholar
• Griffin JE, Gawronski JD, DeJesus MA, Ioerger TR, Akerley BJ, Sassetti CM. 2011. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7(9):e1002251. doi: 10.1371/journal.ppat.1002251.
   PubMed Web of Science ®Google Scholar
• Guerin ME, Kaur D, Somashekar BS, Gibbs S, Gest P, Chatterjee D, Brennan PJ, Jackson M. 2009. New insights into the early steps of phosphatidylinositol mannoside biosynthesis in mycobacteria: pimB′ is an essential enzyme of Mycobacterium smegmatis. J Biol Chem. 284(38):25687–25696. doi: 10.1074/jbc.M109.030593.
   PubMed Web of Science ®Google Scholar
• Gutka HJ, Wang Y, Franzblau SG, Movahedzadeh F. 2015. Glpx gene in mycobacterium tuberculosis is required for in vitro gluconeogenic growth and in vivo survival. PLoS One. 10(9):e0138436. doi: 10.1371/journal.pone.0138436.
   PubMed Web of Science ®Google Scholar
• Härtlova A, Herbst S, Peltier J, Rodgers A, Bilkei-Gorzo O, Fearns A, Dill BD, Lee H, Flynn R, Cowley SA, Davies P, Lewis PA, Ganley IG, Martinez J, Alessi DR, Reith AD, Trost M, Gutierrez MG. 2018. LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages. Embo J. 37:1–17.
   PubMed Web of Science ®Google Scholar
• Heemskerk MT, Korbee CJ, Esselink JJ, dos Santos CC, van Veen S, Gordijn IF, Vrieling F, Walburg KV, Engele CG, Dijkman K, et al. 2021. Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections. Sci Rep. 11(1):19634. doi: 10.1038/s41598-021-98980-z.
   Web of Science ®Google Scholar
• Herbst S, Campbell P, Harvey J, Bernard EM, Papayannopoulos V, Wood NW, Morris HR, Gutierrez MG. 2020. LRRK 2 activation controls the repair of damaged endomembranes in macrophages. Embo J. 39(18):e104494.
   PubMed Web of Science ®Google Scholar
• Hu Y, van der Geize R, Besra GS, Gurcha SS, Liu A, Rohde M, Singh M, Coates A. 2010. 3-Ketosteroid 9α-hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosis. Mol Microbiol. 75(1):107–121. doi: 10.1111/j.1365-2958.2009.06957.x.
   PubMed Web of Science ®Google Scholar
• Hüsler D, Stauffer P, Hilbi H. 2023. Tapping lipid droplets: a rich fat diet of intracellular bacterial pathogens. Mol Microbiol. 120(2):194–209. doi: 10.1111/mmi.15120.
   PubMed Web of Science ®Google Scholar
• Jackson M, Crick DC, Brennan PJ. 2000. Phosphatidylinositol is an essential phospholipid of mycobacteria. J Biol Chem. 275(39):30092–30099. doi: 10.1074/jbc.M004658200.
   PubMed Web of Science ®Google Scholar
• Jackson M, Stevens CM, Zhang L, Zgurskaya HI, Niederweis M. 2021. Transporters involved in the biogenesis and functionalization of the mycobacterial cell envelope. Chem Rev. 121(9):5124–5157. doi: 10.1021/acs.chemrev.0c00869.
   PubMed Web of Science ®Google Scholar
• Jain M, Cox JS. 2005. Interaction between polyketide synthase and transporter suggests coupled synthesis and export of virulence lipid in M. tuberculosis. PLoS Pathog. 1(1):e2. doi: 10.1371/journal.ppat.0010002.
   PubMed Web of Science ®Google Scholar
• Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM. 2013. IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol. 190(8):4196–4204. doi: 10.4049/jimmunol.1202688.
   PubMed Web of Science ®Google Scholar
• Jenum S, Tonby K, Rueegg CS, Rühwald M, Kristiansen MP, Bang P, Olsen IC, Sellæg K, Røstad K, Mustafa T, et al. 2021. A phase I/II randomized trial of H56: IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. Nat Commun. 12(1):6774. doi: 10.1038/s41467-021-27029-6.
   PubMed Web of Science ®Google Scholar
• Johnston JB, Ouellet H, Ortiz De Montellano PR. 2010. Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses. J Biol Chem. 285(47):36352–36360. doi: 10.1074/jbc.M110.161117.
   PubMed Web of Science ®Google Scholar
• Kalscheuer R, Weinrick B, Veeraraghavan U, Besra GS, Jacobs WR. 2010. Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 107(50):21761–21766. doi: 10.1073/pnas.1014642108.
   PubMed Web of Science ®Google Scholar
• Kardan-Yamchi J, Kazemian H, Haeili M, Harati AA, Amini S, Feizabadi MM. 2019. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates. J Glob Antimicrob Resist. 17:201–208. doi: 10.1016/j.jgar.2019.01.003.
   PubMed Web of Science ®Google Scholar
• Kaur D, Berg S, Dinadayala P, Gicquel B, Chatterjee D, McNeil MR, Vissa VD, Crick DC, Jackson M, Brennan PJ, et al. 2006. Biosynthesis of mycobacterial lipoarabinomannan: role of a branching mannosyltransferase. Proc Natl Acad Sci USA. 103(37):13664–13669. doi: 10.1073/pnas.0603049103.
   PubMed Web of Science ®Google Scholar
• Kaur D, McNeil MR, Khoo K-H, Chatterjee D, Crick DC, Jackson M, Brennan PJ. 2007. New insights into the biosynthesis of mycobacterial lipomannan arising from deletion of a conserved gene. J Biol Chem. 282(37):27133–27140. doi: 10.1074/jbc.M703389200.
   PubMed Web of Science ®Google Scholar
• Kaur D, Obregón-Henao A, Pham H, Chatterjee D, Brennan PJ, Jackson M. 2008. Lipoarabinomannan of Mycobacterium: mannose capping by a multifunctional terminal mannosyltransferase. Proc Natl Acad Sci USA. 105(46):17973–17977. doi: 10.1073/pnas.0807761105.
   PubMed Web of Science ®Google Scholar
• Kilinç G, Saris A, Ottenhoff THM. 2021. Haks, M. C. Host-directed therapy to combat mycobacterial infections. Immunol Rev. 301:62–83.
   PubMed Web of Science ®Google Scholar
• Kim SK, Dickinson MS, Finer-Moore J, Guan Z, Kaake RM, Echeverria I, Chen J, Pulido EH, Sali A, Krogan NJ, et al. 2023. Structure and dynamics of the essential endogenous mycobacterial polyketide synthase Pks13. Nat Struct Mol Biol. 30(3):296–308. doi: 10.1038/s41594-022-00918-0.
   PubMedGoogle Scholar
• Kinsella RL, Kimmey JM, Smirnov A, Woodson R, Gaggioli MR, Chavez SM, Kreamalmeyer D, Stallings CL. 2023. Autophagy prevents early proinflammatory responses and neutrophil recruitment during Mycobacterium tuberculosis infection without affecting pathogen burden in macrophages. PLoS Biol. 21(6):e3002159. doi: 10.1371/journal.pbio.3002159.
   PubMed Web of Science ®Google Scholar
• Knapp GS, McDonough KA. 2014. Cyclic AMP signaling in mycobacteria. Microbiol Spectr. 2(2). doi: 10.1128/microbiolspec.MGM2-0011-2013.
   PubMedGoogle Scholar
• Korduláková J, Gilleron M, Mikus̃ová K, Puzo G, Brennan PJ, Gicquel B, Jackson M. 2002. Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis: pimA is essential for growth of mycobacteria. J Biol Chem. 277(35):31335–31344. doi: 10.1074/jbc.M204060200.
   PubMed Web of Science ®Google Scholar
• Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, et al. 2010. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 115(23):4742–4749. doi: 10.1182/blood-2009-10-249540.
   PubMed Web of Science ®Google Scholar
• Kremer L, Gurcha SS, Bifani P, Hitchen PG, Baulard A, Morris HR, Dell A, Brennan PJ, Besra GS. 2002. Characterization of a putative α-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis. Biochem. J. 363(3):437–447. doi: 10.1042/0264-6021:3630437.
   PubMedGoogle Scholar
• Kwai BXC, Collins AJ, Middleditch MJ, Sperry J, Bashiri G, Leung IKH. 2020. Itaconate is a covalent inhibitor of theMycobacterium tuberculosisisocitrate lyase. RSC Med Chem. 12:57–61.
   PubMedGoogle Scholar
• Lachmandas E, Beigier-Bompadre M, Cheng S, Kumar V, van Laarhoven A, Wang X, Ammerdorffer A, Boutens L, de Jong D, Kanneganti T, et al. 2016. Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. Eur J Immunol. 46(11):2574–2586. doi: 10.1002/eji.201546259.
   PubMed Web of Science ®Google Scholar
• Lalvani A, Behr MA, Sridhar S. 2012. Innate immunity to TB: a druggable balancing act. Cell. 148(3):389–391. doi: 10.1016/j.cell.2012.01.026.
   PubMed Web of Science ®Google Scholar
• Laval T, Chaumont L, Demangel C. 2021. Not too fat to fight: the emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis. Immunol Rev. 301(1):84–97. doi: 10.1111/imr.12952.
   PubMed Web of Science ®Google Scholar
• Lea-Smith DJ, Pyke JS, Tull D, McConville MJ, Coppel RL, Crellin PK. 2007. The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan. J Biol Chem. 282(15):11000–11008. doi: 10.1074/jbc.M608686200.
   PubMed Web of Science ®Google Scholar
• Lee W, VanderVen BC, Fahey RJ, Russell DG. 2013. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. Journal of Biological Chemistry. 288(10):6788–6800. doi: 10.1074/jbc.M112.445056.
   PubMed Web of Science ®Google Scholar
• Li Y, Li Y-C, Liu X-T, Zhang L, Chen Y-H, Zhao Q, Gao W, Liu B, Yang H, Li P, et al. 2022. Blockage of citrate export prevents TCA cycle fragmentation via Irg1 inactivation. Cell Rep. 38(7):110391. doi: 10.1016/j.celrep.2022.110391.
   PubMed Web of Science ®Google Scholar
• Lima P, Sidders B, Morici L, Reader R, Senaratne R, Casali N, Riley LW. 2007. Enhanced mortality despite control of lung infection in mice aerogenically infected with a Mycobacterium tuberculosis mce1 operon mutant. Microbes Infect. 9(11):1285–1290. doi: 10.1016/j.micinf.2007.05.020.
   PubMed Web of Science ®Google Scholar
• Lin T-W, Melgar MM, Kurth D, Swamidass SJ, Purdon J, Tseng T, Gago G, Baldi P, Gramajo H, Tsai S-C, et al. 2006. Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 103(9):3072–3077. doi: 10.1073/pnas.0510580103.
   PubMed Web of Science ®Google Scholar
• Mallick I, Santucci P, Poncin I, Point V, Kremer L, Cavalier J-F, Canaan S. 2021. Intrabacterial lipid inclusions in mycobacteria: unexpected key players in survival and pathogenesis? FEMS Microbiology Reviews. 45(6):fuab029. doi: 10.1093/femsre/fuab029.
   PubMed Web of Science ®Google Scholar
• Matsunaga I, Bhatt A, Young DC, Cheng T-Y, Eyles SJ, Besra GS, Briken V, Porcelli SA, Costello CE, Jacobs WR, Jr., et al. 2004. Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J Exp Med. 200(12):1559–1569. doi: 10.1084/jem.20041429.
   PubMed Web of Science ®Google Scholar
• Mattow J, Siejak F, Hagens K, Becher D, Albrecht D, Krah A, Schmidt F, Jungblut PR, Kaufmann SHE, Schaible UE, et al. 2006. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics. 6(8):2485–2494. doi: 10.1002/pmic.200500547.
   PubMed Web of Science ®Google Scholar
• Mehrotra P, Jamwal SV, Saquib N, Sinha N, Siddiqui Z, Manivel V, Chatterjee S, Rao KVS. 2014. Pathogenicity of Mycobacterium tuberculosis Is Expressed by Regulating Metabolic Thresholds of the Host Macrophage. PLoS Pathog. 10(7):e1004265. doi: 10.1371/journal.ppat.1004265.
   PubMed Web of Science ®Google Scholar
• Milad N, Morissette MC. 2021. Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure. Eur Respir Rev. 30(162):210077. doi: 10.1183/16000617.0077-2021.
   PubMed Web of Science ®Google Scholar
• Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, et al. 2018. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 556(7699):113–117. doi: 10.1038/nature25986.
   PubMed Web of Science ®Google Scholar
• Mishra AK, Alderwick LJ, Rittmann D, Tatituri RVV, Nigou J, Gilleron M, Eggeling L, Besra GS. 2007. Identification of an α(1→6) mannopyranosyltransferase (MptA), involved in Corynebacterium glutamicum lipomanann biosynthesis, and identification of its orthologue in Mycobacterium tuberculosis. Mol Microbiol. 65(6):1503–1517. doi: 10.1111/j.1365-2958.2007.05884.x.
   PubMed Web of Science ®Google Scholar
• Mishra AK, Batt S, Krumbach K, Eggeling L, Besra GS. 2009. Characterization of the Corynebacterium glutamicum ΔpimB′ ΔmgtA double deletion mutant and the role of Mycobacterium tuberculosis orthologues Rv2188c and Rv0557 in glycolipid biosynthesis. J Bacteriol. 191(13):4465–4472. doi: 10.1128/JB.01729-08.
   PubMed Web of Science ®Google Scholar
• Morii H, Okauchi T, Nomiya H, Ogawa M, Fukuda K, Taniguchi H. 2013. Studies of inositol 1-phosphate analogues as inhibitors of the phosphatidylinositol phosphate synthase in mycobacteria. J Biochem. 153(3):257–266. doi: 10.1093/jb/mvs141.
   PubMed Web of Science ®Google Scholar
• Morita YS, Sena CBC, Waller RF, Kurokawa K, Sernee MF, Nakatani F, Haites RE, Billman-Jacobe H, McConville MJ, Maeda Y, et al. 2006. PimE is a polyprenol-phosphate-mannose-dependent mannosyltransferase that transfers the fifth mannose of phosphatidylinositol mannoside in mycobacteria. J Biol Chem. 281(35):25143–25155. doi: 10.1074/jbc.M604214200.
   PubMed Web of Science ®Google Scholar
• Movahedzadeh F, Smith DA, Norman RA, Dinadayala P, Murray-Rust J, Russell DG, Kendall SL, Rison SCG, McAlister MSB, Bancroft GJ, et al. 2004. The Mycobactenum tuberculosis ino1 gene is essential for growth and virulence. Mol Microbiol. 51(4):1003–1014. doi: 10.1046/j.1365-2958.2003.03900.x.
   PubMed Web of Science ®Google Scholar
• Movahedzadeh F, Wheeler PR, Dinadayala P, Av-Gay Y, Parish T, Daffé M, Stoker NG. 2010. Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis. BMC Microbiol. 10(1):50. doi: 10.1186/1471-2180-10-50.
   PubMedGoogle Scholar
• Muñoz-Elías EJ, Mckinney JDM. 2005. Tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med. 11(6):638–644. doi: 10.1038/nm1252.
   PubMed Web of Science ®Google Scholar
• Muñoz-Elías EJ, Upton AM, Cherian J, McKinney JD. 2006. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol. 60(5):1109–1122. doi: 10.1111/j.1365-2958.2006.05155.x.
   PubMed Web of Science ®Google Scholar
• Murphy HN, Stewart GR, Mischenko VV, Apt AS, Harris R, McAlister MSB, Driscoll PC, Young DB, Robertson BD. 2005. The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis. J Biol Chem. 280(15):14524–14529. doi: 10.1074/jbc.M414232200.
   PubMed Web of Science ®Google Scholar
• Nazarova EV, Montague CR, La T, Wilburn KM, Sukumar N, Lee W, Caldwell S, Russell DG, VanderVen BC. 2017. Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis. Elife. 6:e26969. doi: 10.7554/eLife.26969.
   PubMed Web of Science ®Google Scholar
• Olzmann JA, Carvalho P. 2019. Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol. 20(3):137–155. doi: 10.1038/s41580-018-0085-z.
   PubMed Web of Science ®Google Scholar
• Pagán AJ, Lee LJ, Edwards-Hicks J, Moens CB, Tobin DM, Busch-Nentwich EM, Pearce EL, Ramakrishnan L. 2022. mTOR-regulated mitochondrial metabolism limits mycobacterium-induced cytotoxicity. Cell. 185(20):3720–3738.e13. doi: 10.1016/j.cell.2022.08.018.
   PubMedGoogle Scholar
• Pandey AK, Sassetti CM. 2008. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci USA. 105(11):4376–4380. doi: 10.1073/pnas.0711159105.
   PubMed Web of Science ®Google Scholar
• Passemar C, Arbués A, Malaga W, Mercier I, Moreau F, Lepourry L, Neyrolles O, Guilhot C, Astarie-Dequeker C. 2014. Multiple deletions in the polyketide synthase gene repertoire of mycobacterium tuberculosis reveal functional overlap of cell envelope lipids in host-pathogen interactions. Cell Microbiol. 16(2):195–213. doi: 10.1111/cmi.12214.
   PubMed Web of Science ®Google Scholar
• Patrick KL, Watson RO. 2021. Mitochondria: powering the innate immune response to Mycobacterium tuberculosis infection. Infect Immun. 89(4):e00687-20. doi: 10.1128/IAI.00687-20.
   PubMed Web of Science ®Google Scholar
• Pawelczyk J, Brzostek A, Kremer L, Dziadek B, Rumijowska-Galewicz A, Fiolka M, Dziadek J. 2011. Accd6, a key carboxyltransferase essential for mycolic acid synthesis in Mycobacterium tuberculosis, is dispensable in a nonpathogenic strain. J Bacteriol. 193(24):6960–6972. doi: 10.1128/JB.05638-11.
   PubMed Web of Science ®Google Scholar
• Pawełczyk J, Brzostek A, Minias A, Płociński P, Rumijowska-Galewicz A, Strapagiel D, Zakrzewska-Czerwińska J, Dziadek J. 2021. Cholesterol-dependent transcriptome remodeling reveals new insight into the contribution of cholesterol to Mycobacterium tuberculosis pathogenesis. Sci Rep. 11(1):1–16. doi: 10.1038/s41598-021-91812-0.
   PubMed Web of Science ®Google Scholar
• Peres-Buzalaf C, de Paula L, Frantz FG, Soares EM, Medeiros AI, Peters-Golden M, Silva CL, Faccioli LH. 2011. Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins. Prostaglandins Leukot Essent Fatty Acids. 85(2):75–81. doi: 10.1016/j.plefa.2011.04.024.
   PubMed Web of Science ®Google Scholar
• Pereverzeva L, van Linge CCA, Schuurman AR, Klarenbeek AM, Ramirez Moral I, Otto NA, Peters-Sengers H, Butler JM, Schomakers BV, van Weeghel M, et al. 2022. Human alveolar macrophages do not rely on glucose metabolism upon activation by lipopolysaccharide. Biochim Biophys Acta Mol Basis Dis. 1868(10):166488. doi: 10.1016/j.bbadis.2022.166488.
   PubMed Web of Science ®Google Scholar
• Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffé M, Emile J-F, Marchou B, Cardona P-J, et al. 2008. Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4(11):e1000204. doi: 10.1371/journal.ppat.1000204.
   PubMed Web of Science ®Google Scholar
• Pisu D, Huang L, Grenier JK, Russell DG. 2020. Dual RNA-seq of Mtb-infected macrophages in vivo reveals ontologically distinct host-pathogen interactions. Cell Rep. 30(2):335–350.e4. doi: 10.1016/j.celrep.2019.12.033.
   PubMed Web of Science ®Google Scholar
• Pohane AA, Carr CR, Garhyan J, Swarts BM, Siegrist MS. 2021. Trehalose recycling promotes energy-efficient biosynthesis of the mycobacterial cell envelope. mBio. 12(1):1–19. doi: 10.1128/mBio.02801-20.
   Web of Science ®Google Scholar
• Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW. 2018. Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. Journal of Infection. 77(6):469–478. doi: 10.1016/j.jinf.2018.10.004.
   PubMed Web of Science ®Google Scholar
• Puckett S, Trujillo C, Eoh H, Marrero J, Spencer J, Jackson M, Schnappinger D, Rhee K, Ehrt S. 2014. Inactivation of fructose-1,6-bisphosphate aldolase prevents optimal co-catabolism of glycolytic and gluconeogenic carbon substrates in mycobacterium tuberculosis. PLoS Pathog. 10(5):e1004144. doi: 10.1371/journal.ppat.1004144.
   PubMed Web of Science ®Google Scholar
• Puech V, Guilhot C, Perez E, Tropis M, Armitige LY, Gicquel B, Daffé M. 2002. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis. Mol Microbiol. 44(4):1109–1122. doi: 10.1046/j.1365-2958.2002.02953.x.
   PubMed Web of Science ®Google Scholar
• Quadri LEN. 2014. Biosynthesis of mycobacterial lipids by polyketide synthases and beyond. Crit Rev Biochem Mol Biol. 49(3):179–211. doi: 10.3109/10409238.2014.896859.
   PubMed Web of Science ®Google Scholar
• Quemard A, Sacchettini JC, Dessen A, Vilcheze C, Bittman R, Jacobs WR, Jr., Blanchard JS. 1995. Enzymatic characterization of the target for isoniazid in mycobacterium tuberculosist. Biochemistry. 34(26):8235–8241. doi: 10.1021/bi00026a004.
   PubMed Web of Science ®Google Scholar
• Quesniaux V, Fremond C, Jacobs M, Parida S, Nicolle D, Yeremeev V, Bihl F, Erard F, Botha T, Drennan M, et al. 2004. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6(10):946–959. doi: 10.1016/j.micinf.2004.04.016.
   PubMed Web of Science ®Google Scholar
• Quigley J, Hughitt VK, Velikovsky CA, Mariuzza RA, El-Sayed NM, Briken V. 2017. The cell wall lipid PDIM contributes to phagosomal escape and host cell exit of Mycobacterium tuberculosis. mBio. 8(2):e00148-17. doi: 10.1128/mBio.00148-17.
   PubMed Web of Science ®Google Scholar
• Rajaram MVS, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS. 2011. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor γ linking mannose receptor recognition to regulation of immune responses. J Immunol. 185(2):929–942. doi: 10.4049/jimmunol.1000866.
   Web of Science ®Google Scholar
• Roca FJ, Whitworth LJ, Redmond S, Jones AA, Ramakrishnan L. 2019. TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit. Cell. 178(6):1344–1361.e11. doi: 10.1016/j.cell.2019.08.004.
   PubMed Web of Science ®Google Scholar
• Roos AK, Burgos E, Ericsson DJ, Salmon L, Mowbray SL. 2005. Competitive inhibitors of Mycobacterium tuberculosis ribose-5-phosphate isomerase B reveal new information about the reaction mechanism. J Biol Chem. 280(8):6416–6422. doi: 10.1074/jbc.M412018200.
   PubMed Web of Science ®Google Scholar
• Ruetz M, Campanello GC, Purchal M, Shen H, McDevitt L, Gouda H, Wakabayashi S, Zhu J, Rubin EJ, Warncke K, et al. 2019. Itaconyl-CoA forms a stable biradical in methylmalonyl-CoA mutase and derails its activity and repair. Science (1979). 366(6465):589–593. doi: 10.1126/science.aay0934.
   Web of Science ®Google Scholar
• Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. 10(9):943–948. doi: 10.1038/ni.1781.
   PubMed Web of Science ®Google Scholar
• Sachdeva K, Goel M, Sudhakar M, Mehta M, Raju R, Raman K, Singh A, Sundaramurthy V. 2020. Mycobacterium tuberculosis (Mtb) lipid mediated lysosomal rewiring in infected macrophages modulates intracellular Mtb trafficking and survival. J Biol Chem. 295(27):9192–9210. doi: 10.1074/jbc.RA120.012809.
   PubMed Web of Science ®Google Scholar
• Samuels AN, Wang ER, Harrison GA, Valenta JC, Stallings CL. 2022. Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance. Front Cell Infect Microbiol. 12:958555. doi: 10.3389/fcimb.2022.958555.
   PubMed Web of Science ®Google Scholar
• Santucci P, Diomandé S, Poncin I, Alibaud L, Viljoen A, Kremer L, de Chastellier C, Canaan S. 2018. Delineating the physiological roles of the PE and catalytic domains of LipY in lipid consumption in mycobacterium-infected foamy macrophages. Infect Immun. 86(9):e00394-18. doi: 10.1128/IAI.00394-18.
   PubMed Web of Science ®Google Scholar
• Santucci P, Smichi N, Diomandé S, Poncin I, Point V, Gaussier H, Cavalier J, Kremer L, Canaan S. 2019. Dissecting the membrane lipid binding properties and lipase activity of Mycobacterium tuberculosis LipY domains. FEBS Journal. 286(16):3164–3181. doi: 10.1111/febs.14864.
   PubMed Web of Science ®Google Scholar
• Sassetti CM, Rubin EJ. 2003. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA. 100(22):12989–12994. doi: 10.1073/pnas.2134250100.
   PubMed Web of Science ®Google Scholar
• Savvi S, Warner DF, Kana BD, McKinney JD, Mizrahi V, Dawes SS. 2008. Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids. J Bacteriol. 190(11):3886–3895. doi: 10.1128/JB.01767-07.
   PubMed Web of Science ®Google Scholar
• Schnappinger D. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J Exp Med. 198:693–704.
   PubMed Web of Science ®Google Scholar
• Seidel M, Alderwick LJ, Birch HL, Sahm H, Eggeling L, Besra GS. 2007. Identification of a novel arabinofuranosyltransferase AftB involved in a terminal step of cell wall arabinan biosynthesis in Corynebacterianeae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J Biol Chem. 282(20):14729–14740. doi: 10.1074/jbc.M700271200.
   PubMed Web of Science ®Google Scholar
• Shao M, McNeil M, Cook GM, Lu X. 2020. MmpL3 inhibitors as antituberculosis drugs. Eur J Med Chem. 200:112390.
   PubMed Web of Science ®Google Scholar
• Sheppe AEF, Edelmann MJ. 2021. Roles of eicosanoids in regulating inflammation and neutrophil migration as an innate host response to bacterial infections. Infect Immun. 89(8):e0009521. doi: 10.1128/IAI.00095-21.
   PubMed Web of Science ®Google Scholar
• Shi W, Chen J, Zhang S, Zhang W, Zhang Y. 2018. Identification of novel mutations in LprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, and cyp128 associated with pyrazinoic acid/pyrazinamide resistance in Mycobacterium tuberculosis. Antimicrob Agent Chemotherap. 62(7):e00430–18.
   PubMed Web of Science ®Google Scholar
• Shimono N, Morici L, Casali N, Cantrell S, Sidders B, Ehrt S, Riley LW. 2003. Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci USA. 100(26):15918–15923. doi: 10.1073/pnas.2433882100.
   PubMed Web of Science ®Google Scholar
• Shin J-H, Yang J-Y, Jeon B-Y, Yoon YJ, Cho S-N, Kang Y-H, Ryu DH, Hwang G-S. 2011. 1H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res. 10(5):2238–2247. doi: 10.1021/pr101054m.
   PubMed Web of Science ®Google Scholar
• Shukla S, Richardson ET, Athman JJ, Shi L, Wearsch PA, McDonald D, Banaei N, Boom WH, Jackson M, Harding CV, et al. 2014. Mycobacterium tuberculosis Lipoprotein LprG Binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion. PLoS Pathog. 10(10):e1004471. doi: 10.1371/journal.ppat.1004471.
   PubMed Web of Science ®Google Scholar
• Simeone R, Bobard A, Lippmann J, Bitter W, Majlessi L, Brosch R, Enninga J. 2012. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog. 8(2):e1002507. doi: 10.1371/journal.ppat.1002507.
   PubMed Web of Science ®Google Scholar
• Siméone R, Constant P, Guilhot C, Daffé M, Chalut C. 2007. Identification of the missing trans-acting enoyl reductase required for phthiocerol dimycocerosate and phenolglycolipid biosynthesis in Mycobacterium tuberculosis. J Bacteriol. 189(13):4597–4602. doi: 10.1128/JB.00169-07.
   PubMed Web of Science ®Google Scholar
• Singh M, Kumar S, Singh B, Jain P, Kumari A, Pahuja I, Chaturvedi S, Prasad DVR, Dwivedi VP, Das G, et al. 2022. The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway. Commun Biol. 5(1). doi: 10.1038/s42003-022-03693-2.
   Web of Science ®Google Scholar
• Siregar TAP, Prombutara P, Kanjanasirirat P, Kunkaew N, Tubsuwan A, Boonmee A, Palaga T, Khumpanied T, Borwornpinyo S, Chaiprasert A, Utaisincharoen P, Ponpuak M. 2022. The autophagy-resistant Mycobacterium tuberculosis Beijing strain upregulates KatG to evade starvation-induced autophagic restriction. Pathog Dis. 80(1):ftac004.
   PubMed Web of Science ®Google Scholar
• Škovierová H, Larrouy-Maumus G, Zhang J, Kaur D, Barilone N, Korduláková J, Gilleron M, Guadagnini S, Belanová M, Prevost M-C, et al. 2009. AftD, a novel essential arabinofuranosyltransferase from mycobacteria. Glycobiology. 19(11):1235–1247. doi: 10.1093/glycob/cwp116.
   PubMed Web of Science ®Google Scholar
• Sorgi CA, Soares EM, Rosada RS, Bitencourt CS, Zoccal KF, Pereira PAT, Fontanari C, Brandão I, Masson AP, Ramos SG, et al. 2020. Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB4 reduction but not PGE2 increment. Biochim Biophys Acta Mol Basis Dis. 1866(3):165574. doi: 10.1016/j.bbadis.2019.165574.
   PubMed Web of Science ®Google Scholar
• Srinivasan L, Ahlbrand S, Briken V. 2014. Interaction of mycobacterium tuberculosis with host cell death pathways. Cold Spring Harb Perspect Med. 4:1–15.
   Web of Science ®Google Scholar
• Su CC, Klenotic PA, Bolla JR, Purdy GE, Robinson CV, Yu EW. 2019. MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine. Proc Natl Acad Sci U S A. 166:11241–11246.
   Google Scholar
• Sulzenbacher G, Canaan S, Bordat Y, Neyrolles O, Stadthagen G, Roig-Zamboni V, Rauzier J, Maurin D, Laval F, Daffé M, et al. 2006. LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. Embo J. 25(7):1436–1444. doi: 10.1038/sj.emboj.7601048.
   PubMed Web of Science ®Google Scholar
• Székely R, Rengifo-Gonzalez M, Singh V, Riabova O, Benjak A, Piton J, Cimino M, Kornobis E, Mizrahi V, Johnsson K, et al. 2020. 6,11-Dioxobenzo [f]pyrido[1,2- a]indoles Kill Mycobacterium tuberculosis by Targeting Iron-Sulfur Protein Rv0338c (IspQ), A Putative Redox Sensor. ACS Infect Dis. 6(11):3015–3025. doi: 10.1021/acsinfecdis.0c00531.
   PubMed Web of Science ®Google Scholar
• Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al. 2013. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 496(7444):238–242. doi: 10.1038/nature11986.
   PubMed Web of Science ®Google Scholar
• Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, Ko DC, Zou Y, Bang ND, Chau TTH, et al. 2012. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 148(3):434–446. doi: 10.1016/j.cell.2011.12.023.
   PubMed Web of Science ®Google Scholar
• Tobin DM, Vary JC, Jr., Ray JP, Walsh GS, Dunstan SJ, Bang ND, Hagge DA, Khadge S, King M-C, Hawn TR, et al. 2010. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell. 140(5):717–730. doi: 10.1016/j.cell.2010.02.013.
   PubMed Web of Science ®Google Scholar
• Trivedi OA, Arora P, Sridharan V, Tickoo R, Mohanty D, Gokhale RS. 2004. Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature. 428(6981):441–445. doi: 10.1038/nature02384.
   PubMed Web of Science ®Google Scholar
• Trivedi OA, Arora P, Vats A, Ansari MZ, Tickoo R, Sridharan V, Mohanty D, Gokhale RS. 2005. Dissecting the mechanism and assembly of a complex virulence mycobacterial lipid. Mol Cell. 17(5):631–643. doi: 10.1016/j.molcel.2005.02.009.
   PubMed Web of Science ®Google Scholar
• Turner J, Torrelles JB. 2018. Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. Pathog Dis. 76(4):fty026.
   PubMed Web of Science ®Google Scholar
• van der Wel N, Hava D, Houben D, Fluitsma D, van Zon M, Pierson J, Brenner M, Peters PJ. 2007. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell. 129(7):1287–1298. doi: 10.1016/j.cell.2007.05.059.
   PubMed Web of Science ®Google Scholar
• VanderVen BC, Fahey RJ, Lee W, Liu Y, Abramovitch RB, Memmott C, Crowe AM, Eltis LD, Perola E, Deininger DD, et al. 2015. Novel inhibitors of cholesterol degradation in mycobacterium tuberculosis reveal how the bacterium’s metabolism is constrained by the intracellular environment. PLoS Pathog. 11(2):e1004679. doi: 10.1371/journal.ppat.1004679.
   PubMed Web of Science ®Google Scholar
• Varela C, Rittmann D, Singh A, Krumbach K, Bhatt K, Eggeling L, Besra GS, Bhatt A. 2012. MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria. Chem Biol. 19(4):498–506. doi: 10.1016/j.chembiol.2012.03.006.
   PubMedGoogle Scholar
• Wallings R, Connor-Robson N, Wade-Martins R. 2019. LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function. Hum Mol Genet. 28(16):2696–2710. doi: 10.1093/hmg/ddz088.
   PubMed Web of Science ®Google Scholar
• Wallis RS, Ginindza S, Beattie T, Arjun N, Likoti M, Edward VA, Rassool M, Ahmed K, Fielding K, Ahidjo BA, et al. 2021. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med. 9(8):897–908. doi: 10.1016/S2213-2600(20)30448-3.
   PubMed Web of Science ®Google Scholar
• Wang Z, Arat S, Magid-Slav M, Brown JR. 2018. Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets. BMC Syst Biol. 12(1):3. doi: 10.1186/s12918-017-0524-z.
   Google Scholar
• Weichhart T, Hengstschläger M, Linke M. 2015. Regulation of innate immune cell function by mTOR. Nat Rev Immunol. 15(10):599–614. doi: 10.1038/nri3901.
   PubMed Web of Science ®Google Scholar
• Weindel CG, Bell SL, Vail KJ, West KO, Patrick KL, Watson RO. 2020. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis. Elife. 9:1–31. doi: 10.7554/eLife.51071.
   Web of Science ®Google Scholar
• Wescott HH, Zuniga ES, Bajpai A, Trujillo C, Ehrt S, Schnappinger D, Roberts DM, Parish T. 2018. Identification of enolase as the target of 2-aminothiazoles in Mycobacterium Tuberculosis. Front Microbiol. 9:2542. doi: 10.3389/fmicb.2018.02542.
   PubMed Web of Science ®Google Scholar
• WHO. 2022. Global tuberculosis report 2022. http://apps.who.int/bookorders.
   Google Scholar
• WHO. Tuberculosis fact sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/tuberculosis.
   Google Scholar
• Wu Y. t, Xu WT, Zheng L, Wang S, Wei J, Liu MY, Zhou HP, Li QF, Shi X, Lv X. 2023. 4-octyl itaconate ameliorates alveolar macrophage pyroptosis against ARDS via rescuing mitochondrial dysfunction and suppressing the cGAS/STING pathway. Int Immunopharmacol. 118:110104.
   PubMed Web of Science ®Google Scholar
• Yam KC, D’Angelo I, Kalscheuer R, Zhu H, Wang J-X, Snieckus V, Ly LH, Converse PJ, Jacobs WR, Strynadka N, et al. 2009. Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis. PLoS Pathog. 5(3):e1000344. doi: 10.1371/journal.ppat.1000344.
   PubMed Web of Science ®Google Scholar
• Yang J, Chen J, Yue J, Liu L, Han M, Wang H. 2014. Relationship between human LTA4H polymorphisms and extra-pulmonary tuberculosis in an ethnic Han Chinese population in Eastern China. Tuberculosis. 94(6):657–663. doi: 10.1016/j.tube.2014.08.014.
   PubMed Web of Science ®Google Scholar
• Yang X, Gao J, Smith I, Dubnau E, Sampson NS. 2011. Cholesterol is not an essential source of nutrition for Mycobacterium tuberculosis during infection. J Bacteriol. 193(6):1473–1476. doi: 10.1128/JB.01210-10.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao Y, Gao Y, Wu L, Gao R, Zhang Q, Wang Y, Wu C, Wu F, Gurcha SS, et al. 2020. Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol. Science (1979). 368(6496):1211–1219. doi: 10.1126/science.aba9102.
   Web of Science ®Google Scholar
• Zimhony O, Vilchèze C, Jacobs WR.Jr. 2004. Characterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) gene. J Bacteriol. 186(13):4051–4055. doi: 10.1128/JB.186.13.4051-4055.2004.
   PubMed Web of Science ®Google Scholar